E
ZYUS Life Sciences Corporation ZYUS.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024
Revenue 4.64% 1.89%
Total Other Revenue -- --
Total Revenue 4.64% 1.89%
Cost of Revenue -3.54% -4.82%
Gross Profit 11.32% 8.84%
SG&A Expenses -32.87% 48.83%
Depreciation & Amortization -0.51% -0.65%
Other Operating Expenses -79.60% 107.70%
Total Operating Expenses -20.43% 42.46%
Operating Income 21.07% -43.91%
Income Before Tax 18.25% -41.81%
Income Tax Expenses -0.81% 1.59%
Earnings from Continuing Operations 18.31% -42.03%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 18.31% -42.03%
EBIT 21.07% -43.91%
EBITDA 24.88% -56.95%
EPS Basic 19.76% -42.12%
Normalized Basic EPS 19.61% -41.36%
EPS Diluted 22.27% -38.01%
Normalized Diluted EPS 19.61% -41.36%
Average Basic Shares Outstanding 1.89% 0.00%
Average Diluted Shares Outstanding 1.89% 0.00%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings